Both in vitro and animal studies have shown that ADAMTS13 has antithrombotic properties (Chauhan et al., 2006), and reduced ADAMTS13 level and activity can increase the risk of cardiovascular disease. This evidence concerns the gene ADAMTS13 and cardiovascular disorder.